The pediatric sepsis biomarker risk model

INTRODUCTION: The intrinsic heterogeneity of clinical septic shock is a major challenge. For clinical trials, individual patient management, and quality improvement efforts, it is unclear which patients are least likely to survive and thus benefit from alternative treatment approaches. A robust risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Hector R, Salisbury, Shelia, Xiao, Qiang, Cvijanovich, Natalie Z, Hall, Mark, Allen, Geoffrey L, Thomas, Neal J, Freishtat, Robert J, Anas, Nick, Meyer, Keith, Checchia, Paul A, Lin, Richard, Shanley, Thomas P, Bigham, Michael T, Sen, Anita, Nowak, Jeffrey, Quasney, Michael, Henricksen, Jared W, Chopra, Arun, Banschbach, Sharon, Beckman, Eileen, Harmon, Kelli, Lahni, Patrick, Lindsell, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682273/
https://www.ncbi.nlm.nih.gov/pubmed/23025259
http://dx.doi.org/10.1186/cc11652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682273/
https://www.ncbi.nlm.nih.gov/pubmed/23025259
http://dx.doi.org/10.1186/cc11652

Ejemplares similares